Perfusion culture method for car-t cells
AssigneeJuventas Cell Therapy Ltd.
InventorsLin SHI, Zhiming XIE, Xiaoyan YANG, Xia JIN, Haoliang TIAN, Huan MENG, Huijuan ZHU, Linsheng HUANG, Xinling LI
Life of this patent
Estimating the term…
Loading patent…
AssigneeJuventas Cell Therapy Ltd.
InventorsLin SHI, Zhiming XIE, Xiaoyan YANG, Xia JIN, Haoliang TIAN, Huan MENG, Huijuan ZHU, Linsheng HUANG, Xinling LI
Estimating the term…
Provided is a perfusion culture method for CAR-T cells. The method comprises the following steps: 1) separating peripheral blood mononuclear cells from a single blood cell of a subject, and sorting the mononuclear cells to obtain T cells; 2) carrying out activation treatment on the separated T cells by using CD3/CD28 stimulation magnetic beads; 3) infecting the activated T cells by using a lentiviral vector; 4) carrying out perfusion culture on the lentivirus-infected T cells, and harvesting CAR-T cells, wherein the composition of a serum-free culture medium, which does not contain an animal-derived component, for culturing the CAR-T cells is: AIM-V+(3-9)% ISR; and the perfusion culture comprises the following stages: the first stage: when the cell density is (0.5-1.1)×106 cells/mL, the perfusion rate is A1, and/or the second stage: when the cell density is (1.1-2)×106 cells/mL, the perfusion rate is A2, and the third stage: when the cell density is >2×106 cells/mL, the perfusion rate is A3, and the ratio of A1 to A2 to A3 is 1:2:2.5.
A perfusion culture method for CAR-T cells, which comprises the following steps:
Dependencies are inferred from the claim text.